A detailed history of Strategic Advocates LLC transactions in Davita Inc. stock. As of the latest transaction made, Strategic Advocates LLC holds 1,976 shares of DVA stock, worth $300,055. This represents 0.12% of its overall portfolio holdings.

Number of Shares
1,976
Previous 2,714 27.19%
Holding current value
$300,055
Previous $376 Million 13.87%
% of portfolio
0.12%
Previous 0.15%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024

SELL
$133.98 - $165.19 $98,877 - $121,910
-738 Reduced 27.19%
1,976 $324 Million
Q2 2024

Jul 11, 2024

SELL
$126.11 - $147.14 $290,053 - $338,421
-2,300 Reduced 45.87%
2,714 $376 Million
Q1 2024

Apr 03, 2024

SELL
$103.89 - $139.21 $35,218 - $47,192
-339 Reduced 6.33%
5,014 $692 Million
Q4 2023

Feb 07, 2024

BUY
$73.2 - $108.8 $25,180 - $37,427
344 Added 6.87%
5,353 $561 Million
Q3 2023

Nov 13, 2023

BUY
$94.53 - $112.68 $473,500 - $564,414
5,009 New
5,009 $474 Million

Others Institutions Holding DVA

About DAVITA INC.


  • Ticker DVA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Care Facilities
  • Shares Outstandng 91,300,000
  • Market Cap $13.9B
  • Description
  • DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine lab...
More about DVA
Track This Portfolio

Track Strategic Advocates LLC Portfolio

Follow Strategic Advocates LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Strategic Advocates LLC, based on Form 13F filings with the SEC.

News

Stay updated on Strategic Advocates LLC with notifications on news.